|
Catherine Dargan is a partner in our corporate group with broad experience in mergers and acquisitions, public and private securities offerings, finance and advisory work, new venture formations, and strategic partnering arrangements. In addition to structuring and negotiating transactions, she assists clients with corporate governance issues, securities law and indenture compliance, credit agreements, employment and consulting arrangements, and other matters. Ms. Dargan also regularly advises clients on a variety of commercial agreements relating to manufacturing, supply, and distribution of core products.
She represents clients in a variety of industries including life sciences, consumer products, technology, communications and media; sports and entertainment; pharmaceutical, equipment, and food product manufacturing; and consulting and advisory services.
Representative Matters
- Advised Intercell AG, an Austrian biotechnology company, in its $189 million acquisition of Iomai Corporation, a NASDAQ listed developer of vaccines and vaccine delivery systems.
- The Procter & Gamble Company in its 50/50 joint venture with Inverness Medical Innovations, Inc. for the development, manufacturing, marketing and sale of existing and to-be-developed consumer diagnostic products in a transaction valued at $650 million.
- Represented Abbott Laboratories in its $3.7 billion acquisition of Kos Pharmaceuticals, Inc.
- Advised Hanesbrands, Inc. on its separation and $2.4 billion spin-off from Sara Lee Corporation as a new publicly traded company on the New York Stock Exchange.
- Represented Eisai Co., Ltd. and Eisai Inc. in the $130 million acquisition of rights to Zonegran(TM) (zonisamide), an anti-epileptic drug, held by Elan Corporation, plc and the acquisition of four oncology drugs for $205 million from Ligand Pharmaceuticals Inc.
Pro Bono
- Represented a non-profit, non-partisan policy organization dedicated to engaging young adults in the political process.
- Advised a non-profit in various consulting and services arrangements.
|